Lalani Tahaniyat, Maguire Jason D, Grant Edward M, Fraser Jamie, Ganesan Anuradha, Johnson Mark D, Deiss Robert G, Riddle Mark S, Burgess Timothy, Tribble David R
Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; Division of Infectious Diseases, Naval Medical Center, Portsmouth, VA, USA.
J Travel Med. 2015 May-Jun;22(3):152-60. doi: 10.1111/jtm.12179. Epub 2014 Dec 7.
Infectious diarrhea is a common problem among travelers. Expert guidelines recommend the prompt use of antibiotics for self-treatment of moderate or severe travelers' diarrhea (TD). There is limited data on whether travelers follow these self-treatment guidelines. We evaluated the risk factors associated with TD, the use of TD self-treatment, and the risk of irritable bowel syndrome (IBS) during travel.
Department of Defense beneficiaries traveling outside the United States for ≤6.5 months were enrolled in a prospective cohort study. Participants received pre- and post-travel surveys, and could opt into a travel illness diary and follow-up surveys for symptoms of IBS. Standard definitions were used to assess for TD and IBS. Suboptimal self-treatment was defined as the use of antibiotics (with or without antidiarrheal agents) for mild TD, or the use of antidiarrheals alone or no self-treatment in cases of moderate or severe TD.
Twenty-four percent of participants (270/1,120) met the criteria for TD. The highest incidence was recorded in Africa [8.6 cases/100 person-weeks, 95% confidence interval (CI): 6.7-10.5]. Two hundred and twelve participants with TD provided information regarding severity and self-treatment: 89 (42%) had mild TD and 123 (58%) had moderate or severe TD. Moderate or severe TD was independently associated with suboptimal self-treatment [OR 10.4 (95% CI: 4.92-22.0)]. Time to last unformed stool did not differ between optimal and suboptimal self-treatment. IBS occurred in 4.5% (7/154) of TD cases and in 3.1% (16/516) of cases without TD (p = 0.39). Among TD cases, a lower incidence of IBS was noted in participants who took antibiotics [4.8% (5/105) vs 2.2% (1/46)] in those who did not, but the difference did not reach statistical significance (p = 0.60).
Our results suggest the underutilization of antibiotics in travelers with moderate or severe TD. Further studies are needed to systematically evaluate pre-travel instruction and traveler adherence to self-treatment guidelines, and the impact of suboptimal self-treatment on outcomes.
感染性腹泻是旅行者中常见的问题。专家指南建议对中度或重度旅行者腹泻(TD)进行自我治疗时应及时使用抗生素。关于旅行者是否遵循这些自我治疗指南的数据有限。我们评估了与TD相关的危险因素、TD自我治疗的使用情况以及旅行期间肠易激综合征(IBS)的风险。
在美国境外旅行≤6.5个月的国防部受益人参加了一项前瞻性队列研究。参与者在旅行前和旅行后接受调查,并可选择加入旅行疾病日记和IBS症状的随访调查。采用标准定义评估TD和IBS。自我治疗不当定义为轻度TD使用抗生素(有或无止泻药),或中度或重度TD单独使用止泻药或未进行自我治疗。
24%的参与者(270/1120)符合TD标准。非洲的发病率最高[8.6例/100人周,95%置信区间(CI):6.7-10.5]。212名TD参与者提供了有关严重程度和自我治疗的信息:89名(42%)为轻度TD,123名(58%)为中度或重度TD。中度或重度TD与自我治疗不当独立相关[比值比10.4(95%CI:4.92-22.0)]。最佳自我治疗和自我治疗不当之间最后一次不成形大便的时间没有差异。IBS发生在4.5%(7/154)的TD病例和3.1%(16/516)的非TD病例中(p = 0.39)。在TD病例中,服用抗生素的参与者IBS发病率较低[4.8%(5/105)对2.2%(1/46)],未服用抗生素的参与者IBS发病率较低,但差异未达到统计学意义(p = 0.60)。
我们的结果表明,中度或重度TD旅行者对抗生素的使用不足。需要进一步研究系统评估旅行前指导和旅行者对自我治疗指南的依从性,以及自我治疗不当对结果的影响。